Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
BCN PEPTIDES
Mediona, Spain
A
11-50 Employees
1989
Key takeaway
The company specializes in the GMP manufacture of bioactive peptides for pharmaceutical, veterinary, and cosmetic applications, emphasizing high quality and extensive experience in peptide drug development.
Reference
Core business
BCNpeptides
Aptadel Therapeutics
Barcelona, Spain
A
1-10 Employees
2020
Key takeaway
Aptadel Therapeutics is a pre-clinical stage biotech company that develops RNA Aptamer technologies to deliver various therapeutic agents, including siRNA and chemotherapeutic drugs, directly into cancer cells. Their innovative approach targets multiple oncology indications, showcasing their commitment to advancing cancer treatment.
Reference
Core business
Home - Aptadel Therapeutics
Aptadel Therapeutics is a pre-clinical stage drug development biotech company based on RNA Aptamer technology for the treatment of cancer.
ENDOLIPID THERAPEUTICS
Barcelona, Spain
A
1-10 Employees
2021
Key takeaway
Endolipid is focused on developing peptide nanoformulations for targeted drug delivery, particularly in applications related to NASH and cellulite.
Reference
Core business
EndoLipiD Therapeutics - EndoLipiD Therapeutics
Endolipid is developing applications in NASH and Cellulite
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
DIVERSA Technologies
Santiago de Compostela, Spain
A
1-10 Employees
2022
Key takeaway
The company focuses on providing innovative drug delivery solutions, particularly for peptide therapeutics, which are essential for overcoming biological barriers in drug development. Their DIVERSA peptide delivery reagents are designed to enhance the efficacy of pharmaceutical products, ultimately improving patient outcomes.
Reference
Core business
Diversa technologies - DIVERSA
Drug delivery solutions for research and pharma
POLYPEPTIDE THERAPEUTIC SOLUTIONS S.L.
Paterna, Spain
A
11-50 Employees
2012
Key takeaway
PTS specializes in the design and manufacturing of nanoparticle delivery systems, which aligns with the growing field of peptide therapeutics. Their expertise in polymer synthesis and advanced drug delivery systems supports therapeutic programs from discovery to commercialization, making them a key player in innovative drug development.
Reference
Product
Home - PTS
IDP Pharma
Barcelona, Spain
A
1-10 Employees
2015
Key takeaway
IDP Pharma is focused on developing peptide therapeutics that target intrinsically disordered proteins (IDPs), which are linked to various diseases and have been difficult to address. Their innovative platform creates drug candidates that modulate IDP function, offering potential breakthrough treatments for conditions like cancer.
Reference
Core business
- IDP PHARMA
Novel Therapeutic Targets Unlocking intrinsically disordered proteins (IDPs), disease drivers up to now considered intractable by the industry, to bring disruptive therapies into patients. Proprietary Technology Our Platform delivers drug candidates that modulate the function of IDPs by retaining them in an inactive, disordered state, activating their degradation by cells’ intrinsic machinery. Unmet Medical Needs […]
BioPharma Synergies
Barcelona, Spain
A
1-10 Employees
2006
Key takeaway
BioPharma Synergies specializes in connecting manufacturers with market demands, particularly in the European market. They have a dedicated R&D team that focuses on developing and improving active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms (FDF), and they are introducing an innovative drug delivery system that enhances the appeal of these products.
Reference
Product
Portfolio | BioPharma Synergies
Telum Therapeutics
Noáin (Valle de Elorz)/Noain (Elortzibar), Spain
A
11-50 Employees
-
Key takeaway
Telum Therapeutics SL is a biotechnology company focused on developing innovative antimicrobial agents using engineered phage lytic proteins, known as enzybiotics. Their mission is to address drug-resistant infections, which is highly relevant to the field of peptide therapeutics.
Reference
Core business
Telum Therapeutics - The science of today is the technology of tomorrow.
Telum Therapeutics SL is a global drug discovery biotechnologycompany specializing in the use of Innovative Phage LyticProteins as antibiotics.
Nanoligent
Cerdanyola del Vallès, Spain
A
1-10 Employees
-
Key takeaway
Nanoligent is focused on developing targeted drug therapies through advanced protein engineering and nanobiotechnology, which enhances treatment effectiveness and reduces side effects. Their innovative approach targets CXCR4 to inhibit tumor growth and metastasis, with potential applications beyond cancer, indicating a commitment to revolutionizing targeted drug delivery for various conditions.
Reference
Core business
Nanoligent – A biotech company
TPNBT - Technical Proteins Nanobiotechnology
Valladolid, Spain
A
1-10 Employees
2010
Key takeaway
Technical Proteins is focused on the design and development of therapeutic platforms, which may include innovative approaches relevant to peptide therapeutics.
Reference
Core business
TPNBT - Technical Proteins Nanobiotechnology
Technical Proteins Nanobiotechnology TPNBT
Technologies which have been searched by others and may be interesting for you:
When exploring the Peptide Therapeutics industry in Spain, several key considerations come into play. Regulatory frameworks are crucial; the Spanish Agency of Medicines and Medical Devices (AEMPS) oversees the approval and monitoring of peptide-based therapies, ensuring compliance with both national and European Union standards. Understanding these regulations is essential for navigating the market effectively. Challenges include the high costs associated with research and development, as well as the need for innovative technologies to enhance peptide stability and delivery. However, the industry presents significant opportunities, particularly with Spain's growing investment in biotechnology and strong academic research institutions that foster collaboration between academia and industry. Environmental concerns related to peptide synthesis and waste management must also be addressed, as sustainability becomes increasingly important in pharmaceutical development. The competitive landscape is dynamic, with both established companies and startups vying for market share, which emphasizes the importance of differentiating products through innovation. Additionally, the global market for peptide therapeutics is expanding, driven by increasing demand for targeted therapies, thus positioning Spain as a potential hub for growth in this sector. Overall, a thorough understanding of these factors will aid in effectively navigating the Peptide Therapeutics industry in Spain.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Spain |
| Amount of fitting manufacturers | 197 |
| Amount of suitable service providers | 161 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Peptide Therapeutics?
Start-Ups who are working in Peptide Therapeutics are ENDOLIPID THERAPEUTICS, DIVERSA Technologies
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Pharmaceuticals, Other, Healthcare, Chemicals
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.